Physician

Tuow Daniel Ting, M.D.,PH.D.

According to 2025 Medicare claims, Tuow Ting, M.D., PH.D. (NPI: 1043244437) practices ophthalmology in the Oakland-Fremont-Berkeley, CA market, with the plurality of this provider's patient population coming from Alameda, CA. This provider's primary affiliated billing organization is BAY AREA RETINA ASSOCIATES (NPI: 1174557805; TIN: 94-3064464) and primary practice location at 94609-3235.

Ting's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,082 traditional Medicare patients, billed 43,177 HCPCS/CPT codes, and received $3,112,938 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 330 prescription claims across 94 beneficiaries totaling $21,104 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 5 records totaling $156. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $1,311,754 to $3,112,938. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $46,540 and ending at $21,104. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	680	6,196	$1,311,754
2016	705	6,702	$1,308,830
2017	743	8,805	$1,800,891
2018	808	9,235	$1,984,031
2019	842	9,110	$2,095,050
2020	754	8,014	$1,989,137
2021	794	8,926	$2,313,408
2022	918	13,355	$2,488,129
2023	1,068	27,221	$2,744,816
2024	1,082	43,177	$3,112,938

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	65	206	$46,540
2016	68	259	$54,344
2017	76	326	$118,806
2018	114	405	$139,751
2019	96	321	$150,263
2020	82	314	$77,635
2021	105	427	$107,904
2022	110	442	$105,064
2023	125	513	$79,063
2024	94	330	$21,104

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
92014	Established patient complete exam of visual system	665	856	$110
67028	Injection of drug into eye	359	1,792	$109
92012	Established patient problem focused exam of visual system	392	568	$84
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	331	976	$78
92134	Imaging of retina	1,018	2,927	$37

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Prednisolone Acetate	Prednisolone Acetate	86	4,667	$4,808
Ketorolac Tromethamine	Ketorolac Tromethamine	74	3,357	$2,324
Difluprednate	Difluprednate	12	418	$981
Moxifloxacin	Moxifloxacin Hcl	34	544	$662
Dorzolamide Hcl	Dorzolamide Hcl	38	2,417	$531

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	5	$156	Genentech USA, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Tuow Daniel Ting, M.D., PH.D.?

Tedicare shows public-source Medicare data for Tuow Daniel Ting, M.D., PH.D. (NPI 1043244437), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Tuow Daniel Ting, M.D., PH.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Tuow Daniel Ting, M.D., PH.D.?

Tuow Daniel Ting, M.D., PH.D. is linked to BAY AREA RETINA ASSOCIATES (billing NPI 1174557805) in the available physician profile data.

Does Tuow Daniel Ting, M.D., PH.D. have Open Payments data?

Tuow Daniel Ting, M.D., PH.D. has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.